IFNA1, Human (Sifalimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IFNA1, Human (Sifalimumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIFNA1, Human (Sifalimumab biosimilar)
CloneSifalimumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IFNA1 Recombinant Antibody (Sifalimumab). Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab was developed by MedImmune, as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials.
Immunogenn/a
Other NamesAnti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab, Anti-Human IFNA1 Recombinant Antibody(Sifalimumab), MDX-1103, MEDI-545, Antibody Drug Analogues, Monoclonal Antibody, YR1217, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1006877-41-3
Catalog #YR1217
Priceplease inquire
Order / More InfoIFNA1, Human (Sifalimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.